Ryosuke Ando

Nagoya City University

Papers

6

Total Citations

104

H-Index

5

About

Dr. Ryosuke Ando is a pioneering urologic surgeon whose research focuses on advancing minimally invasive robotic techniques for kidney stone disease and prostate cancer surgery. His most impactful work includes a landmark randomized clinical trial comparing robotic-assisted fluoroscopic-guided versus ultrasound-guided renal access for percutaneous nephrolithotomy (PCNL), which has garnered 33 citations and demonstrated the potential for improved precision in kidney stone removal. Dr. Ando has also made significant contributions to optimizing functional outcomes after robot-assisted radical prostatectomy, particularly through his studies on Retzius-sparing approaches that aim to accelerate early urinary continence recovery. His research on extraperitoneal versus transperitoneal approaches in Japanese patients has helped tailor surgical techniques to specific patient populations. With multiple high-impact publications in leading urology journals, Dr. Ando’s work has been cited over 100 times, reflecting its influence on clinical practice. His innovative use of phantom model benchtop studies to validate new robotic systems before clinical implementation exemplifies his commitment to evidence-based surgical innovation. Dr. Ando continues to shape the future of robotic urologic surgery through rigorous clinical trials and outcomes research.

Research Focus

Key Achievements

5
H-Index
6
Papers
104
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A Randomized, Single-Blind Clinical Trial Comparing Robotic-Assisted Fluoroscopic-Guided with Ultrasound-Guided Renal Access for Percutaneous Nephrolithotomy
33 citations · 2022
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Nagoya City University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago